Functional analysis of the mismatch repair system in bladder cancer

In bladder cancer the observed microsatellite instability indicates that mismatch repair deficiency could be a frequently involved factor in bladder cancer progression. To investigate this hypothesis we analysed extracts of seven bladder cancer cell lines and, as a novel approach, five clinical cancer samples for mismatch repair activity. We found that one cell line (T24) and three of the clinical samples had a reduced repair capacity, measured to ~20% or less. The T24 cell extract was unable to repair a G-G mismatch and showed reduced repair of a 2-base loop, consistent with diminished function of the MSH2-MSH6 heterodimer. The functional assay was combined with measurement for mutation frequency, microsatellite analysis, sequencing, MTT assay, immunohistochemical analysis and RT-PCR analysis of the mismatch repair genes MSH2, MSH3, MSH6, PMS1, PMS2 and MLH1. A >7-fold relative increase in mutation frequency was observed for T24 compared to a bladder cancer cell line with a fully functional mismatch repair system. Neither microsatellite instability, loss of repair nor mismatch repair gene mutations were detected. However, RT-PCR analysis of mRNA levels did detect changes in the ratio of expression of the Mut S and Mut L homologues. The T24 cell line had the lowest MSH6 expression level of the cell lines tested. Identical RT-PCR analysis of seventeen clinical samples (normal urothelium, 7; pTa low stage, 5; and pT1-4 high stage, 5) indicated a significant change in the expression ratio between MSH3/MSH6 (P < 0.004), MSH2/MSH3 (P < 0.012) and PMS2/MLH1 P < 0.005, in high stage bladder tumours compared to normal urothelium and low stage tumours. Collectively, the data suggest that imbalanced expression of mismatch repair genes could lead to partial loss of mismatch repair activity that is associated with invasive bladder cancer. © 2001 Cancer Research Campaign http://www.bjcancer.com

[1]  B. Glickman,et al.  Human DNA repair systems: An overview , 1999, Environmental and molecular mutagenesis.

[2]  M. Gardner,et al.  Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. , 1977, Journal of the National Cancer Institute.

[3]  D. Sidransky,et al.  Evidence for two bladder cancer suppressor loci on human chromosome 9. , 1993, Cancer research.

[4]  A. Lindblom,et al.  Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours , 1999, British Journal of Cancer.

[5]  T. Ørntoft,et al.  Pronounced microsatellite instability in transitional cell carcinomas from young patients with bladder cancer , 1998, International journal of cancer.

[6]  N. Kleckner,et al.  Functional specificity of MutL homologs in yeast: evidence for three Mlh1-based heterocomplexes with distinct roles during meiosis in recombination and mismatch correction. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Fogh.  Cultivation, characterization, and identification of human tumor cells with emphasis on kidney, testis, and bladder tumors. , 1978, National Cancer Institute monograph.

[8]  D. Ledbetter,et al.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.

[9]  I. Arzimanoglou,et al.  Microsatellite instability in human solid tumors , 1998, Cancer.

[10]  R. Lothe,et al.  Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. , 1995, Human Molecular Genetics.

[11]  D. Sidransky,et al.  Microsatellite instability in bladder cancer. , 1993, Cancer research.

[12]  R. Liskay,et al.  Mammalian DNA mismatch repair. , 1999, Annual review of genetics.

[13]  G. Aquilina,et al.  Effect of hMSH6 cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15. , 1999, Carcinogenesis.

[14]  M. Knowles,et al.  Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. , 1993, Cancer research.

[15]  H. Ozen.  Bladder cancer. , 1998, Current opinion in oncology.

[16]  M. Knowles,et al.  Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. , 1993, Oncogene.

[17]  C. Busch,et al.  Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer. , 1999, Anticancer Research.

[18]  J. L. Fink,et al.  Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  L. Gu,et al.  ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair. , 1998, Nucleic acids research.

[20]  G. Marsischky,et al.  Eukaryotic DNA mismatch repair. , 1999, Current opinion in genetics & development.

[21]  W. McCombs,et al.  Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice. , 1984, Cancer research.

[22]  N. B. Atkin.  Microsatellite instability , 2001, Cytogenetic and Genome Research.

[23]  T. Kunkel,et al.  Functional overlap in mismatch repair by human MSH3 and MSH6. , 1998, Genetics.

[24]  P. Modrich,et al.  Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. , 1995, Science.

[25]  T. Kunkel,et al.  Mismatch repair in extracts of Werner syndrome cell lines. , 1997, Cancer research.

[26]  T. Kunkel,et al.  Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. , 1997, Cancer research.

[27]  S. Brewster,et al.  Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. , 1994, British Journal of Cancer.

[28]  A. Viel,et al.  MLH1 and MSH2 constitutinal mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer , 1998, International journal of cancer.

[29]  P. Modrich,et al.  DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSα/hMutSβ ratio and reduces the efficiency of base–base mismatch repair , 1997 .

[30]  T. Kunkel,et al.  Mutator Phenotypes Conferred by MLH1Overexpression and by Heterozygosity for mlh1Mutations , 1999, Molecular and Cellular Biology.

[31]  S. Devries,et al.  Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization , 1995, Genes, chromosomes & cancer.

[32]  T. Kunkel,et al.  DNA loop repair by human cell extracts. , 1994, Science.

[33]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.

[34]  M. Knowles,et al.  Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. , 1994, Oncogene.

[35]  J. Jiricny,et al.  Mismatch repair deficiency associated with overexpression of the MSH3 gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Kunkel,et al.  Measurement of Heteroduplex Repair in Human Cell Extracts , 1995 .

[37]  T. Polascik,et al.  Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. , 1995, Cancer research.

[38]  R. Lothe,et al.  Microsatellite instability in human solid tumors. , 1997, Molecular medicine today.

[39]  C. Rigby,et al.  A Human Tissue Culture Cell Line from a Transitional Cell Tumour of the Urinary Bladder: Growth, Chromosome Pattern and Ultrastructure , 1970, British Journal of Cancer.

[40]  H. Wolf,et al.  The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines. , 1996, Cancer research.

[41]  C. Cordon-Cardo,et al.  Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. , 1994, Cancer research.

[42]  Paul Modrich,et al.  Isolation of MutSβ from Human Cells and Comparison of the Mismatch Repair Specificities of MutSβ and MutSα* , 1998, The Journal of Biological Chemistry.

[43]  P. Modrich,et al.  DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha/hMutSbeta ratio and reduces the efficiency of base-base mismatch repair. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Cordon-Cardo,et al.  Molecular genetic alterations in superficial and locally advanced human bladder cancer. , 1991, Cancer research.

[45]  R. Simon,et al.  Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. , 1999, The Journal of pathology.

[46]  T. Shuin,et al.  Retinoblastoma gene mutations in primary human bladder cancer. , 1995, British Journal of Cancer.

[47]  P. Lichter,et al.  Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. , 1995, The American journal of pathology.

[48]  Daniel S. Miller,et al.  Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. , 1999, Journal of the National Cancer Institute.

[49]  E Liu,et al.  p53 mutations in bladder tumors from arylamine-exposed workers. , 1996, Cancer research.

[50]  Satya Prakash,et al.  ATP-dependent Assembly of a Ternary Complex Consisting of a DNA Mismatch and the Yeast MSH2-MSH6 and MLH1-PMS1 Protein Complexes* , 1998, The Journal of Biological Chemistry.

[51]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.